Profile for Sanjay Srivastava, PhD

Sanjay Srivastava

Sanjay Srivastava, PhD

  • University Distinguished Professor
  • Department Chairperson
  • Director
  • University Distinguished Professor
  • Associate Academic Dean
Office Phone: 325-696-0464
Mail Address: 1406 S Coulter St
Amarillo TX 79106-1786


Dr. Sanjay K. Srivastava is currently a Distinguished Professor and Chair of Department of Immunotherapeutics and Biotechnology specializing in Cancer Biology, Chemoprevention and Therapeutics. He is also the Associate Dean for Sciences. Previously, he was a Professor in the Department of Biomedical Sciences. Prior to his arrival at TTUHSC, Dr. Srivastava served as an Assistant Professor in the Department of Pharmacology, University of Pittsburgh School of Medicine and was a full member of the University of Pittsburgh Cancer Institute. He did his post-doc from the University of Texas Medical Branch at Galveston, Texas. Dr. Srivastava’s research is focused on melanoma, brain cancer, breast cancer, pancreatic cancer, and ovarian cancer and is funded by grants from the National Cancer Institute, NIH. He has authored around 150 research papers and is the Editor of three books. Dr. Srivastava is in the editorial board of several journals and is the member of societies including American Association for Cancer Research, Society of Toxicology and AAPS. He also serves in the grant review panels of National Institute of Health (NIH), Department of Defense and Susan G. Komen Breast Cancer Foundation. His research work has been featured by news agencies including BBC, MSNBC, CBS, ABC, Science News etc.

Selected Publications:

  • Verma K, Gupta N, Zang T, Wangtrakluldee P, Srivastava SK, Penning TM, Trippier P. AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells.. Molecular cancer therapeutics 2018;17(9):1833-1845.
  • Jung JH, Jung DB, Kim H, Lee H, Kang SE, Srivastava SK, Yun M, Kim S. Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.. Oncogene 2018;37(27):3715-3728.
  • Kim CG, Lee H, Gupta N, Ramachandran S, Kaushik I, Srivastava SK, Kim S, Srivastava SK. Role of Forkhead Box Class O proteins in cancer progression and metastasis.. Seminars in cancer biology 2018;50:142-151.
  • Awasthi S, Tompkins J, Singhal J, Riggs AD, Yadav S, Wu X, Singh S, Warden C, Liu Z, Wang J, Slavin TP, Weitzel JN, Yuan YC, Awasthi M, Srivastava SK, Awasthi YC, Singhal SS. Rlip depletion prevents spontaneous neoplasia in TP53 null mice.. Proceedings of the National Academy of Sciences of the United States of America 2018;115(15):3918-3923.
  • Kwon HY, Kim J, Kim B, Srivastava SK, Kim S. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.. Archives of toxicology 2018;92(1):241-257.